SpringWorks Therapeutics Inc (SWTX)
42.92
+2.82
(+7.03%)
USD |
NASDAQ |
Apr 22, 16:00
42.88
-0.04
(-0.08%)
After-Hours: 20:00
SpringWorks Therapeutics Total Assets (Quarterly): 725.79M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 725.79M |
| September 30, 2023 | 467.65M |
| June 30, 2023 | 517.33M |
| March 31, 2023 | 569.20M |
| December 31, 2022 | 630.24M |
| September 30, 2022 | 681.55M |
| June 30, 2022 | 365.92M |
| March 31, 2022 | 405.58M |
| December 31, 2021 | 452.49M |
| September 30, 2021 | 495.28M |
| Date | Value |
|---|---|
| June 30, 2021 | 520.43M |
| March 31, 2021 | 554.59M |
| December 31, 2020 | 576.19M |
| September 30, 2020 | 286.10M |
| June 30, 2020 | 301.02M |
| March 31, 2020 | 317.41M |
| December 31, 2019 | 334.83M |
| September 30, 2019 | 348.40M |
| June 30, 2019 | 194.63M |
| December 31, 2018 | 48.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
194.63M
Minimum
Jun 2019
725.79M
Maximum
Dec 2023
460.24M
Average
467.65M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | 612.88M |
| Alnylam Pharmaceuticals Inc | 3.830B |
| Geron Corp | 394.08M |
| Ionis Pharmaceuticals Inc | 2.990B |
| Madrigal Pharmaceuticals Inc | 640.55M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 99.57M |
| Shareholders Equity (Quarterly) | 626.22M |
| Current Ratio | 6.408 |